Clinical Trials Directory

Trials / Completed

CompletedNCT03465007

Steroids on Intra-dialytic Hypotension

Effects of Corticosteroids on Intra-dialytic Hypotension

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
82 (actual)
Sponsor
University of Jordan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Symptomatic hypotension during (or immediately following) hemodialysis complicates 5 to 30 percent of all dialysis treatments and is associated with increased morbidity and mortality. Kidney Disease Outcomes Quality Initiative (KDOQI) and European Best Practice Guidelines define intradialytic hypotension as the presence of a decrease in systolic blood pressure ≥20 mmHg or a decrease in mean arterial pressure by 10 mmHg, providing the decrease in blood pressure is associated with clinical events and need for nursing interventions. Common causes of intradialytic hypotension include excessive or rapid ultrafiltration, high blood flow during dialysis, CHF, taking the antihypertensive medications prior to HD, and others. One of the possible reasons that is surprisingly has not been approached worldwide for intra-dialytic hypotension could be more prevalent adrenal insufficiency in ESRD patients or a delay in the appropriate rise of endogenous serum cortisol given hemodialysis is considered by all means a stressful condition to the body. Investigators will assess first the prevalence of intradialytic hypotension at JUH dialysis unit. Investigators will screen patients who developed intradialytic hypotension for adrenal insufficiency by ordering random am cortisol. Then Investigators will give IV Hydrocortisone 100 mg prior to HD to patients who developed intra-dialytic hypotension and monitor their BP response during the HD treatments for 3 HD sessions (1 week, 3 HD sessions). After that, the same patients will receive 100 mg normal saline for 3 HD sessions. Both the administrator and the patient will be blinded for the interventions.

Conditions

Interventions

TypeNameDescription
DRUGHydrocortisonewe will give IV Hydrocortisone 100 mg prior to HD to the patients who developed intra-dialytic hypotension and monitor their BP response during the HD treatments.
DRUGNormal salinewe will give IV normal saline 100 mg prior to HD to the patients who developed intra-dialytic hypotension and monitor their BP response during the HD

Timeline

Start date
2017-10-22
Primary completion
2018-07-25
Completion
2019-02-01
First posted
2018-03-14
Last updated
2019-04-08

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT03465007. Inclusion in this directory is not an endorsement.

Steroids on Intra-dialytic Hypotension (NCT03465007) · Clinical Trials Directory